RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
Key facts
- Who runs it
- Boston University
- Where
- Boston, Minneapolis, and Philadelphia, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 172 people, planned
- Started
- 15 Sept 2025
- Expected to end
- Jan 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- RISE
- Advocacy-based ECAU
- Record updated
- 30 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC)
- report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and
- be able to provide informed consent including permission to have intervention sessions recorded
Who cannot take part
- severe cognitive impairment,
- suicide or homicide intent with a specific plan
- untreated or unstable symptoms of mania or psychosis
This trial is currently available in United States.
- VA Boston Healthcare SystemBoston, United StatesContact: Katherine M Iverson, PhDTaking people
- VA Minneapolis Healthcare SystemMinneapolis, United StatesContact: Princess Ackland, PhDTaking people
- VA Philadelphia Healthcare SystemPhiladelphia, United StatesContact: Melissa Dichter, PhDTaking people
About the trial
What the trial wants to find out
This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health.
Read full original descriptionShow less
Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.
The 2 groups in the trial
- RISE (Recovering from Intimate Partner Violence through Strengths and Empowerment)Treatment being tested
Participants randomized to the RISE arm will have 1 or more RISE sessions.
Treatment: RISE
- Advocacy-based ECAU (Enhanced Care as Usual)Existing treatment, for comparison
Participants randomized to this arm will have a single Advocacy-based ECAU session
Treatment: Advocacy-based ECAU
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Recovering From IPV Through Strengths and Empowerment (RISE) Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
- Record updated
- 30 September 2026